Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 20393030 | HCID 20393030 | — |
| Reactant | HCID 20487347 | HCID 20487347 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 20393036 | HCID 20393036 | — |
Reaction Steps
A mixture consisting of 12.3 gm of 6,11-dihydro-2,4,6-trimethyl-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one, 120 ml of dimethyl formamide and 3.05 gm of 50% sodium hydride in mineral oil was stirred at 60° C. for 2 hours. Thereafter, 17 gm of 3-(N-ethyl-N-benzyl-amino)-propyl chloride were added dropwise, and the solution was stirred at 120° C. for 2 hours. After evaporating the solution in vacuo, the residue was distilled, yielding 68% of theory of 11-[3-(N-ethyl-N-benzyl-amino)-propyl]-6,11-dihydro-2,4,6-trimethyl-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one having a b.p. of 236°-238° C. at 0.3 mm Hg.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04167570 |
|---|
| Source dataset | uspto-grants-1979_09 |
|---|
| ORD ID | ord-bced3e7e80094562b37006932fa7340b |
|---|
| Source note | uspto-grants-1979_09 |
|---|